GSK hopes for vaccine success as new shot enters late-stage trial
GlaxoSmithKline PLC updates Sign up to myFT Daily Digest to be the first to know about GlaxoSmithKline PLC news. A third Covid-19 shot using GlaxoSmithKline’s adjuvant technology has entered a late-stage clinical trial as the UK drugmaker seeks to make up lost ground in the development of a coronavirus vaccine. The vaccine, produced by South…
Read more